BaseLaunch

NXI Therapeutics develops next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.

Salvina Therapeutics is developing novel antibodies targeting TNF to overcome efficacy barriers in inflammatory and autoimmune diseases.

Phialogics is focuses on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.

FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.

Onena Medicines is a biotechnology company provides medical devices, antibodies to treat cancer and rare diseases.

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.

Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.

PharmaBiome is specialized in the isolation, characterization, and technology of novel intestinal microbes.

Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.